Senator Kohl further investigates the regulation of US DTC device ads
This article was originally published in Clinica
Executive Summary
US Senator Herb Kohl, the chairman of the Senate’s special committee on ageing, has written a letter to Congressman Bart Stupak, chairman of the House energy and commerce subcommittee on oversight and investigations, recommending co-operation on an approach towards regulating direct-to-consumer (DTC) advertising of medical devices.
You may also be interested in...
US: The sun shines in on industry-doctor relationships
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Global regulators/industry to gather in US and Germany to talk device regulation
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.
Global regulators and industry execs to gather in US and Germany to talk device regulation
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.